MA56396A - Polymorphes de 1-(2-((((trans)-3-fluoro-1-(3-fluoropyridin-2-yl)cyclobutyl)méthyl)amino)pyrimidin-5-yl)-1h-pyrrole-3-carboxamide - Google Patents
Polymorphes de 1-(2-((((trans)-3-fluoro-1-(3-fluoropyridin-2-yl)cyclobutyl)méthyl)amino)pyrimidin-5-yl)-1h-pyrrole-3-carboxamideInfo
- Publication number
- MA56396A MA56396A MA056396A MA56396A MA56396A MA 56396 A MA56396 A MA 56396A MA 056396 A MA056396 A MA 056396A MA 56396 A MA56396 A MA 56396A MA 56396 A MA56396 A MA 56396A
- Authority
- MA
- Morocco
- Prior art keywords
- fluoropyridin
- polymorphs
- pyrimidin
- carboxamide
- pyrrole
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962867834P | 2019-06-27 | 2019-06-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA56396A true MA56396A (fr) | 2022-05-04 |
Family
ID=71728912
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA056396A MA56396A (fr) | 2019-06-27 | 2020-06-26 | Polymorphes de 1-(2-((((trans)-3-fluoro-1-(3-fluoropyridin-2-yl)cyclobutyl)méthyl)amino)pyrimidin-5-yl)-1h-pyrrole-3-carboxamide |
Country Status (13)
Country | Link |
---|---|
US (1) | US20220315558A1 (fr) |
EP (1) | EP3990447A1 (fr) |
JP (1) | JP2022538119A (fr) |
KR (1) | KR20220079512A (fr) |
CN (1) | CN114364669A (fr) |
AU (1) | AU2020308017A1 (fr) |
BR (1) | BR112021025659A2 (fr) |
CA (1) | CA3142514A1 (fr) |
CL (1) | CL2021003380A1 (fr) |
IL (1) | IL289397A (fr) |
MA (1) | MA56396A (fr) |
MX (1) | MX2021015468A (fr) |
WO (1) | WO2020264358A1 (fr) |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3239345A (en) | 1965-02-15 | 1966-03-08 | Estrogenic compounds and animal growth promoters | |
US4411890A (en) | 1981-04-14 | 1983-10-25 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
US4036979A (en) | 1974-01-25 | 1977-07-19 | American Cyanamid Company | Compositions containing 4,5,6,7-tetrahydrobenz[b]thien-4-yl-ureas or derivatives and methods of enhancing growth rate |
AU628322B2 (en) | 1988-01-28 | 1992-09-17 | Eastman Kodak Company | Polypeptide compounds having growth hormone releasing activity |
EP0400051B1 (fr) | 1988-01-28 | 1995-05-10 | Polygen Holding Corporation | Composes polypeptidiques ayant une activite de liberation d'une hormone de croissance |
US5663146A (en) | 1991-08-22 | 1997-09-02 | Administrators Of The Tulane Educational Fund | Polypeptide analogues having growth hormone releasing activity |
US5776983A (en) | 1993-12-21 | 1998-07-07 | Bristol-Myers Squibb Company | Catecholamine surrogates useful as β3 agonists |
US5488064A (en) | 1994-05-02 | 1996-01-30 | Bristol-Myers Squibb Company | Benzo 1,3 dioxole derivatives |
US5491134A (en) | 1994-09-16 | 1996-02-13 | Bristol-Myers Squibb Company | Sulfonic, phosphonic or phosphiniic acid β3 agonist derivatives |
US5541204A (en) | 1994-12-02 | 1996-07-30 | Bristol-Myers Squibb Company | Aryloxypropanolamine β 3 adrenergic agonists |
WO1997021993A2 (fr) | 1995-12-13 | 1997-06-19 | The Regents Of The University Of California | Ligands de recepteurs nucleaires et domaines de liaison de ligands |
US5770615A (en) | 1996-04-04 | 1998-06-23 | Bristol-Myers Squibb Company | Catecholamine surrogates useful as β3 agonists |
GB9713739D0 (en) | 1997-06-27 | 1997-09-03 | Karobio Ab | Thyroid receptor ligands |
US6548529B1 (en) | 1999-04-05 | 2003-04-15 | Bristol-Myers Squibb Company | Heterocyclic containing biphenyl aP2 inhibitors and method |
AR081331A1 (es) * | 2010-04-23 | 2012-08-08 | Cytokinetics Inc | Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos |
CA3087051A1 (fr) * | 2017-12-26 | 2019-07-04 | Cytokinetics, Incorporated | Procede de preparation d'une amino-pyrimidine et de ses intermediaires |
-
2020
- 2020-06-26 EP EP20743441.6A patent/EP3990447A1/fr active Pending
- 2020-06-26 JP JP2021576595A patent/JP2022538119A/ja not_active Withdrawn
- 2020-06-26 KR KR1020227002356A patent/KR20220079512A/ko unknown
- 2020-06-26 MX MX2021015468A patent/MX2021015468A/es unknown
- 2020-06-26 CA CA3142514A patent/CA3142514A1/fr active Pending
- 2020-06-26 CN CN202080047114.5A patent/CN114364669A/zh active Pending
- 2020-06-26 AU AU2020308017A patent/AU2020308017A1/en not_active Abandoned
- 2020-06-26 MA MA056396A patent/MA56396A/fr unknown
- 2020-06-26 WO PCT/US2020/039906 patent/WO2020264358A1/fr active Application Filing
- 2020-06-26 BR BR112021025659A patent/BR112021025659A2/pt unknown
- 2020-06-26 US US17/621,950 patent/US20220315558A1/en active Pending
-
2021
- 2021-12-16 CL CL2021003380A patent/CL2021003380A1/es unknown
- 2021-12-26 IL IL289397A patent/IL289397A/en unknown
Also Published As
Publication number | Publication date |
---|---|
BR112021025659A2 (pt) | 2022-02-08 |
CA3142514A1 (fr) | 2020-12-30 |
WO2020264358A1 (fr) | 2020-12-30 |
US20220315558A1 (en) | 2022-10-06 |
CN114364669A (zh) | 2022-04-15 |
AU2020308017A1 (en) | 2022-02-10 |
MX2021015468A (es) | 2022-01-24 |
EP3990447A1 (fr) | 2022-05-04 |
JP2022538119A (ja) | 2022-08-31 |
CL2021003380A1 (es) | 2022-08-19 |
IL289397A (en) | 2022-02-01 |
KR20220079512A (ko) | 2022-06-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3934562T3 (da) | Klæberetainer | |
DK3750456T3 (da) | Fleksibelt element til formning af engangsbestik | |
MA56396A (fr) | Polymorphes de 1-(2-((((trans)-3-fluoro-1-(3-fluoropyridin-2-yl)cyclobutyl)méthyl)amino)pyrimidin-5-yl)-1h-pyrrole-3-carboxamide | |
JP1643045S (ja) | プリンター | |
JP1641212S (ja) | プリンター | |
DK3825135T3 (da) | Substratprintsystem | |
JP1654518S (ja) | プリンター | |
UA41771S (uk) | Етикетка до клею «десмокол» | |
UA41625S (uk) | Етикетка до клею «будапрен» | |
UA38651S (uk) | Етикетка для клею «s&g nayaritoff» | |
ES1280510Y (es) | Material de oficina | |
UA39701S (uk) | Комплект етикеток для пива «waissburg світле» | |
UA42492S (uk) | Малюнок для опаковання «аха мюслі» | |
UA42178S (uk) | Малюнок для опаковання «аха каша» | |
UA39472S (uk) | Малюнок для опакування «гліцин» | |
UA39682S (uk) | Комплект етикеток «ludovic» | |
IT201900004683A1 (it) | Paracolpi per superfici | |
UA39703S (uk) | Комплект етикеток для пива «waissburg міцне» | |
UA40346S (uk) | Бургер «block burger» | |
UA38650S (uk) | Етикетка до клею для взуття «interhim s&g ходоскор» | |
UA40984S (uk) | Етикетка «ля рошель» | |
UA41382S (uk) | Сковорода «таlко» | |
UA41386S (uk) | Сковорода «talko» | |
UA42491S (uk) | Малюнок для опаковання «аха muesli one moment made» | |
UA39385S (uk) | Малюнок для опаковання «аха каша» |